Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage
The DOME study is a clinical trial exploring a new treatment approach for patients who suffered a severe brain bleed due to an aneurysm.
| Condition(s) | Aneurysmal Subarachnoid Hemorrhage |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The DOME study is a clinical trial exploring a new treatment approach for patients who suffered a severe brain bleed due to an aneurysm. |
| Who can participate | Inclusion Criteria: * 18 years or older * CT confirmed aSAH with an angiographically detected aneurysm * World Federation of Neurological Sciences (WFNS) aSAH grade 3-5 aneurysm * LAR available and gives consent within 72 hours after the onset of aSAH (or last known normal Exclusion Criteria: * Patients whose aneurysm judged appropriate for balloon-assisted coiling * Patients whose aneurysm is bleeding from the "neck" * Patients who are clinically judged to suffer imminent death within 24 hours. * Pregnancy or positive urine pregnancy test |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University of Louisville |
| Locations | Louisville, Kentucky, United States |
| Start date | 2026-03-12 |
| NCT ID | NCT07250958 |
| Official listing | https://clinicaltrials.gov/study/NCT07250958 |